Study offers a foundation for additional research to examine radiation and immune response
Meta-analysis suggests efficacy and safety
Key abstracts highlight advances in treating locally advanced and refractory disease
Treatment decision must be balanced against toxicity concerns
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
How a novel tissue marker makes a difference
Positioning the technology in the current therapeutic landscape
Findings may help predict radiotherapy outcomes